CIK: 1402604 - Address: 3201 Carnegie Avenue, Cleveland, OH 44115-2634
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1180-2481-02
S%wins63637563757569

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/21/15 17:35
9/18/15
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.m-131.361-10-1902D-24-6-5813221714111-9-16-237847
6/19/15 18:04
6/18/14
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.m-121.231-10-1845D-29-27-2-622-8-41-16-421-1779
3/19/15 18:27
3/18/15
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.m-293.104-10-1865D98-1613214353206101-10-57-63-62-23
12/19/14 18:38
12/18/14
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.m-121.290-10-1896D25-37-19-9-18-10-520-550148-13-26
9/22/14 18:22
9/18/14
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.m-131.410-10-1917D-5-23-58-12-9036-1-1-6-9132-5
6/19/14 21:16
6/18/14
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS.dm-161.631-10-1927D11-4-19-557-5-1-4-12-3-15-23-24
3/20/14 17:01
3/18/14
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS-343.544-10-1858D128136110787-8-12-5-13-23-53-61-11
12/20/13 18:40
12/18/13
ATHXAthersys, Inc / NewDEHealthDrugPharmaceutical PreparationsVan Bokkelen GilOHDOCB,CEOS-192.033-10-1887D201103318291947129355-29-38

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact